What is New in AML: Risk Classification, Germline Mutations, and Targeted Therapies
What is New in AML: Risk Classification, Germline Mutations…
349 viewsMay 29, 2024
vumedi.com
Treatment Options for AML Patients with IDH2, RUNX1, or DNMT3A Mutations | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Treatment Options for AML Patients with IDH2, RUNX1, or DNMT3A Mu…
Aug 8, 2022
targetedonc.com
Dr. Hamilton on Prognostic Impact of Molecular Mutations in AML and MDS on HCT Outcomes | OncLive
Dr. Hamilton on Prognostic Impact of Molecular Mutations in AML an…
Jan 29, 2016
onclive.com
Genomic Sequencing and Identifying Driver Mutations in AML and MDS | OncLive
Genomic Sequencing and Identifying Driver Mutations in AM…
Jan 25, 2020
onclive.com
IDH Mutations in AML | OncLive
IDH Mutations in AML | OncLive
Jul 20, 2020
onclive.com
Dr. Mims on Developed Mutations in AML | OncLive
Dr. Mims on Developed Mutations in AML | OncLive
Jan 15, 2020
onclive.com
Establishing the Role of FLT3 Mutations in AML | OncLive
Establishing the Role of FLT3 Mutations in AML | OncLive
Sep 20, 2018
onclive.com
Prognostic Impact of FLT3 Mutations in AML | OncLive
2 weeks ago
onclive.com
Patient Profile 2: Patient with de novo AML and IDH2 Mutation | On…
Jun 16, 2022
onclive.com
Dr. Wang Discusses FLT3 Mutations in AML | OncLive
Jun 25, 2017
onclive.com
Dr Winer on the Efficacy of Emavusertib in AML With FLT3 an…
Feb 28, 2025
onclive.com
Dr. Levis on Gilteritinib in Relapsed/Refractory FLT3-Mutate…
4 months ago
onclive.com
Dr. Pemmaraju on the Challenges of Targeting TP53 Mutations in MDS/…
Jun 9, 2020
onclive.com
6:43
FLT3 Mutations’ Impact on Prognosis and Treatment in AML
4.4K viewsOct 11, 2018
YouTubeOncLive
Dr Patel on the p53 IHC Positivity as Potential Surrogate for Multi-Hit T…
7 months ago
onclive.com
FLAG-IDA venetoclax for the treatment of patients with newly di…
Feb 4, 2021
aml-hub.com
Dr. Steensma on Midostaurin for Patients With AML | OncLive
Dec 6, 2015
onclive.com
2:57
Targeting IDH mutations for the treatment of AML
371 viewsMay 25, 2018
YouTubeVJHemOnc – Video Journal of Hematology & H…
Dr Wang on the Role of Menin Inhibitors in Genetically Defined A…
11 months ago
onclive.com
5:00
NPM1 mutations in AML: What are they, and how do they influence th…
308 views7 months ago
YouTubeKnow AML
1:54
NPM1 mutations in AML: What are they, and how do they influence th…
580 views7 months ago
YouTubeKnow AML
3:14
FLT3 mutations for targeted therapy in AML
198 viewsSep 27, 2018
YouTubeVJHemOnc – Video Journal of Hematology & H…
0:11
Acute myeloid leukemia, or #AML for short, is an aggressive type of …
113.8K viewsFeb 24, 2021
FacebookAstellas Pharma US
1:19
Webinar | FLT3 mutations in AML: Types, prevalence, and clinical sig…
106 views1 month ago
YouTubeAML Hub
1:33
The current guidelines and therapies for TP53-mutated MDS a…
1.5K viewsJun 26, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
16:18
Symposium | FLT3 mutations in AML: Types, prevalence, and clini…
229 views2 months ago
YouTubeAML Hub
1:52
The role of MRD monitoring in the management of FLT3-mutated AML
67 views8 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
51:09
Understanding FLT3 in AML: What It Means and How It’s Treated
482 views10 months ago
YouTubeHealthTree University for Blood Cancers
2:31
IDH mutations in AML treated with venetoclax
168 viewsJan 25, 2021
YouTubeVJHemOnc – Video Journal of Hematology & H…
5:16
An analysis of TP53 mutation in AML and HR-MDS
714 viewsJan 27, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
See more videos
Static thumbnail place holder